RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hisamitsu Pharmaceutical Co Stock

Hisamitsu Pharmaceutical Co Debt 2024

Hisamitsu Pharmaceutical Co Debt

-110,359 JPY

Ticker

4530.T

ISIN

JP3784600003

WKN

864341

In 2024, Hisamitsu Pharmaceutical Co's total debt was -110,359 JPY, a -12.99% change from the -126,830 JPY total debt recorded in the previous year.

Hisamitsu Pharmaceutical Co Aktienanalyse

What does Hisamitsu Pharmaceutical Co do?

Hisamitsu Pharmaceutical Co Inc is a Japanese company that was founded in 1847. The company is known for its patches and other medical products, making it one of the largest pharmaceutical manufacturers in Japan. The company specializes in the development and production of pharmaceuticals, medical devices, and health and beauty products. They have four main business areas: pharmaceutical products, health products, medical devices, and cosmetics. In addition to their popular Salonpas patches, they also offer a range of other medications, health products, medical devices, and cosmetics. Hisamitsu is committed to improving health and well-being through innovation and collaboration with research institutions and universities. Hisamitsu Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Hisamitsu Pharmaceutical Co's Debt Structure

Hisamitsu Pharmaceutical Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Hisamitsu Pharmaceutical Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Hisamitsu Pharmaceutical Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Hisamitsu Pharmaceutical Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Hisamitsu Pharmaceutical Co stock

What is the debt of Hisamitsu Pharmaceutical Co this year?

Hisamitsu Pharmaceutical Co has a debt level of -110,359 JPY this year.

What was the debt of Hisamitsu Pharmaceutical Co compared to the previous year?

The debt of Hisamitsu Pharmaceutical Co has increased by -12.99% compared to the previous year dropped.

What are the consequences of high debt for investors in Hisamitsu Pharmaceutical Co?

High debt can pose a risk for investors of Hisamitsu Pharmaceutical Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Hisamitsu Pharmaceutical Co?

Low debt means that Hisamitsu Pharmaceutical Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Hisamitsu Pharmaceutical Co affect the company?

An increase in debt of Hisamitsu Pharmaceutical Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Hisamitsu Pharmaceutical Co affect the company?

A reduction in debt of Hisamitsu Pharmaceutical Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Hisamitsu Pharmaceutical Co?

Some factors that can influence the debt of Hisamitsu Pharmaceutical Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Hisamitsu Pharmaceutical Co so important for investors?

The debts of Hisamitsu Pharmaceutical Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Hisamitsu Pharmaceutical Co take to change the debt?

To change the debt, Hisamitsu Pharmaceutical Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Hisamitsu Pharmaceutical Co pay?

Over the past 12 months, Hisamitsu Pharmaceutical Co paid a dividend of 85.5 JPY . This corresponds to a dividend yield of about 1.91 %. For the coming 12 months, Hisamitsu Pharmaceutical Co is expected to pay a dividend of 86.59 JPY.

What is the dividend yield of Hisamitsu Pharmaceutical Co?

The current dividend yield of Hisamitsu Pharmaceutical Co is 1.91 %.

When does Hisamitsu Pharmaceutical Co pay dividends?

Hisamitsu Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of September, March, September, March.

How secure is the dividend of Hisamitsu Pharmaceutical Co?

Hisamitsu Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Hisamitsu Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 86.59 JPY are expected. This corresponds to a dividend yield of 1.93 %.

In which sector is Hisamitsu Pharmaceutical Co located?

Hisamitsu Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hisamitsu Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hisamitsu Pharmaceutical Co from 11/1/2024 amounting to 2 JPY, you needed to have the stock in your portfolio before the ex-date on 8/29/2024.

When did Hisamitsu Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Hisamitsu Pharmaceutical Co in the year 2023?

In the year 2023, Hisamitsu Pharmaceutical Co distributed 84.5 JPY as dividends.

In which currency does Hisamitsu Pharmaceutical Co pay out the dividend?

The dividends of Hisamitsu Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hisamitsu Pharmaceutical Co

Our stock analysis for Hisamitsu Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hisamitsu Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.